|
|
hindbrain tangential cell migration
|
GO:0021934 |
2 |
0.660
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.577
|
|
|
|
neural crest cell migration involved in autonomic nervous system development
|
GO:1901166 |
5 |
0.508
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.365
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.364
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.344
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.333
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.320
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.255
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.251
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.235
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.234
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.222
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.220
|
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
20 |
0.219
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.216
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.212
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.202
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.197
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.197
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.193
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.190
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.188
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.185
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.178
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.177
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.176
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.176
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.175
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.171
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.171
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.171
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.168
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.163
|
|
|
|
branch elongation involved in ureteric bud branching
|
GO:0060681 |
3 |
0.162
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.161
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.158
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.157
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.156
|
|
|
|
ascending aorta morphogenesis
|
GO:0035910 |
3 |
0.155
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.153
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.152
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.152
|
|
|
|
oculomotor nerve morphogenesis
|
GO:0021622 |
2 |
0.151
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.150
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.149
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.149
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.148
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.148
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.143
|
|
|
|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902256 |
2 |
0.142
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.133
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.128
|
|
|
|
rhombomere development
|
GO:0021546 |
8 |
0.127
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.126
|
|
|
|
negative regulation of glial cell differentiation
|
GO:0045686 |
21 |
0.124
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.121
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.121
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.120
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.118
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.118
|
|
|
|
negative regulation of astrocyte differentiation
|
GO:0048712 |
10 |
0.117
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.114
|
|
|
|
endothelin receptor signaling pathway
|
GO:0086100 |
3 |
0.114
|
|
|
|
noradrenergic neuron differentiation
|
GO:0003357 |
6 |
0.113
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.112
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.112
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.111
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.111
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.111
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
19 |
0.111
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.109
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.108
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.107
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.107
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.106
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.106
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.105
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.105
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.104
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.103
|
|
|
|
aorta development
|
GO:0035904 |
23 |
0.102
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.101
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.097
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.097
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.096
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.096
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.096
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.095
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.094
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.093
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.093
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.091
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.090
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.089
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.088
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.088
|
|
|
|
apoptotic process involved in outflow tract morphogenesis
|
GO:0003275 |
2 |
0.087
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.087
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.087
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.086
|
|
|
|
positive regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014718 |
2 |
0.086
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.085
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.085
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.085
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.083
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.083
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.082
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.081
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.081
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.081
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.081
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.080
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.080
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.080
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.080
|
|
|
|
circadian behavior
|
GO:0048512 |
13 |
0.079
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.079
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.078
|
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.078
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.078
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.078
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.078
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.078
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.077
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.076
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.075
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.074
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.074
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.074
|
|
|
|
negative regulation of skeletal muscle cell differentiation
|
GO:2001015 |
1 |
0.073
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.073
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.073
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.072
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.072
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.071
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.071
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.071
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.071
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.070
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.070
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.070
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.070
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.070
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.069
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.069
|
|
|
|
male sex determination
|
GO:0030238 |
14 |
0.068
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.068
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.067
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.067
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.067
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.066
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.066
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.066
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.065
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.065
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.064
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.064
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.064
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.064
|
|
|
|
sinoatrial node cell development
|
GO:0060931 |
3 |
0.064
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.064
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.063
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.063
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.063
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.062
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.061
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.060
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.060
|
|
|
|
vascular smooth muscle contraction
|
GO:0014829 |
5 |
0.060
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.060
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.060
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.060
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.060
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.060
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.059
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.059
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.058
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.058
|
|
|
|
regulation of neuron maturation
|
GO:0014041 |
5 |
0.058
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.058
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.058
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.058
|
|
|
|
trochlear nerve development
|
GO:0021558 |
3 |
0.058
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.057
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.057
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.057
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.057
|
|
|
|
respiratory system process
|
GO:0003016 |
25 |
0.057
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.056
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.056
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.056
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.056
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.055
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.055
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.054
|
|
|
|
myoblast migration
|
GO:0051451 |
8 |
0.054
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.054
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.054
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.054
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.054
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.053
|
|
|
|
regulation of oligodendrocyte differentiation
|
GO:0048713 |
23 |
0.053
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.053
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.053
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.052
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.052
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.052
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.052
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.052
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.051
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.051
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
27 |
0.051
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.051
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.051
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.051
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.051
|
|
|
|
urea homeostasis
|
GO:0097274 |
2 |
0.050
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.050
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.050
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.049
|
|
|
|
regulation of rac protein signal transduction
|
GO:0035020 |
19 |
0.049
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.049
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.049
|
|
|
|
myotome development
|
GO:0061055 |
4 |
0.049
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.049
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.049
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.048
|
|
|
|
artery smooth muscle contraction
|
GO:0014824 |
2 |
0.048
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.048
|
|
|
|
ductus arteriosus closure
|
GO:0097070 |
3 |
0.048
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.048
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.048
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
23 |
0.048
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.048
|
|
|
|
ventricular cardiac muscle cell differentiation
|
GO:0055012 |
17 |
0.048
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.047
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.047
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.047
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.047
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.047
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.047
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.047
|
|
|
|
fungiform papilla morphogenesis
|
GO:0061197 |
5 |
0.047
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.047
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.046
|
|
|
|
retinal rod cell differentiation
|
GO:0060221 |
2 |
0.046
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.046
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.046
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.046
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.046
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.046
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.046
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.046
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.046
|
|
|
|
renal capsule specification
|
GO:0072130 |
1 |
0.046
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.046
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.045
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.045
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.045
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.045
|
|
|
|
neural crest cell fate commitment
|
GO:0014034 |
1 |
0.045
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.045
|
|
|
|
negative regulation of branching involved in ureteric bud morphogenesis
|
GO:0090191 |
4 |
0.045
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.044
|
|
|
|
optic vesicle morphogenesis
|
GO:0003404 |
2 |
0.044
|
|
|
|
posterior midgut development
|
GO:0007497 |
1 |
0.044
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.044
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.044
|
|
|
|
g0 to g1 transition
|
GO:0045023 |
3 |
0.044
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.043
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.043
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.043
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.043
|
|
|
|
oculomotor nerve development
|
GO:0021557 |
4 |
0.043
|
|
|
|
otolith morphogenesis
|
GO:0032474 |
3 |
0.043
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.043
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.043
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.042
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.042
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.042
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.042
|
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.042
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.042
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.041
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.041
|
|
|
|
cranial ganglion development
|
GO:0061550 |
5 |
0.041
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.041
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.041
|
|
|
|
positive regulation of muscle hypertrophy
|
GO:0014742 |
2 |
0.041
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.041
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.040
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.040
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.040
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.040
|
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.040
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.040
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.040
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.039
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.039
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.039
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.039
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.039
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.039
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.039
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.039
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.039
|
|
|
|
rhombomere 3 development
|
GO:0021569 |
4 |
0.039
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.039
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.038
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.038
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.038
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.038
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.038
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.037
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.037
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.037
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.037
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.037
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.037
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.037
|
|
|
|
positive regulation of odontogenesis
|
GO:0042482 |
4 |
0.037
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.037
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.037
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.037
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.037
|
|
|
|
copulation
|
GO:0007620 |
7 |
0.037
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.037
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.036
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.036
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.036
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.036
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.036
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.036
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.036
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.036
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.036
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.036
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.036
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.036
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.036
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.036
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.035
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.035
|
|
|
|
soft palate development
|
GO:0060023 |
2 |
0.035
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.035
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.035
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.035
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.035
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.035
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.034
|
|
|
|
pancreas morphogenesis
|
GO:0061113 |
3 |
0.034
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.034
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.034
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.034
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.034
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.034
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.034
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.034
|
|
|
|
retinal bipolar neuron differentiation
|
GO:0060040 |
5 |
0.034
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.034
|
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.034
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.034
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.034
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.033
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.033
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.033
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.033
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.033
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.033
|
|
|
|
astrocyte development
|
GO:0014002 |
12 |
0.033
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.033
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.033
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.033
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.033
|
|
|
|
tricuspid valve development
|
GO:0003175 |
3 |
0.033
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.033
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.033
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.033
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.032
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.032
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.032
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.032
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.032
|
|
|
|
locus ceruleus development
|
GO:0021703 |
1 |
0.032
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.032
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.032
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.032
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.032
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.032
|
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.032
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.032
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.032
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.032
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.031
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.031
|
|
|
|
heart field specification
|
GO:0003128 |
6 |
0.031
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.031
|
|
|
|
maternal process involved in parturition
|
GO:0060137 |
1 |
0.031
|
|
|
|
receptor recycling
|
GO:0001881 |
11 |
0.031
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.031
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.031
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.031
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.031
|
|
|
|
tangential migration from the subventricular zone to the olfactory bulb
|
GO:0022028 |
5 |
0.031
|
|
|
|
trigeminal ganglion development
|
GO:0061551 |
5 |
0.031
|
|
|
|
positive regulation of mesenchymal cell proliferation involved in ureter development
|
GO:2000729 |
3 |
0.031
|
|
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
20 |
0.030
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.030
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.030
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.030
|
|
|
|
response to morphine
|
GO:0043278 |
9 |
0.029
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.029
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.029
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.029
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.029
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.029
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.029
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.029
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.029
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.029
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.029
|
|
|
|
otic placode formation
|
GO:0043049 |
1 |
0.029
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.029
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.028
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.028
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.028
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.028
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.028
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.028
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.028
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.028
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.028
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.028
|
|
|
|
nose development
|
GO:0043584 |
12 |
0.028
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.028
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.027
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.027
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.027
|
|
|
|
regulation of branch elongation involved in ureteric bud branching
|
GO:0072095 |
3 |
0.027
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.027
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.027
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.027
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.027
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.027
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.027
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.027
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.027
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.027
|
|
|
|
regulation of satellite cell proliferation
|
GO:0014842 |
5 |
0.027
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.026
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.026
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.026
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.026
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.026
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.026
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.026
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.026
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.026
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.026
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.026
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.026
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.026
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.026
|
|
|
|
endocardium development
|
GO:0003157 |
10 |
0.026
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.026
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.026
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.026
|
|
|
|
corticotropin hormone secreting cell differentiation
|
GO:0060128 |
3 |
0.026
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.025
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.025
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.025
|
|
|
|
regulation of skeletal muscle cell differentiation
|
GO:2001014 |
11 |
0.025
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.025
|
|
|
|
skeletal muscle tissue regeneration
|
GO:0043403 |
20 |
0.025
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.025
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.025
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.025
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.025
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.025
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.025
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.025
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.025
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.025
|
|
|
|
facial nerve development
|
GO:0021561 |
11 |
0.025
|
|
|
|
renal capsule formation
|
GO:0072129 |
1 |
0.025
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.025
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.025
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.025
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.025
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.025
|
|
|
|
positive regulation of oligodendrocyte differentiation
|
GO:0048714 |
9 |
0.025
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.025
|
|
